American Peptide Company’s new Total Peptide Management program leverages the experience and expertise of American Peptide Company’s leadership team to help customers properly select peptides and follow the correct procedures and compliance guidelines to streamline the drug development and manufacture process.
Additionally, the program facilitates greater adherence to manufacturing standards and protocols at the company’s manufacturing facilities. It mandates application of GMP practices to non-GMP applications in the early phases of drug development to provide drug researchers with manufacturing processes that can be scaled up efficiently.
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 5, May, 2008, pp. 9.
Filed Under: Drug Discovery
